Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News PureTech Health ADR Representing 10 Ord Shs PRTC

Healthcare Biotechnology
PureTech Health plc is a clinical stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company's R&D engine has resulted in the development of around 29 therapeutics and therapeutic candidates, including two that have received both United States Food and Drug Administration (FDA) clearance and European... see more

Recent & Breaking News (NDAQ:PRTC)

PureTech to Present at Two Upcoming Investor Conferences

Business Wire 1 day ago

PureTech Founded Entity Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round

Business Wire 10 days ago

PureTech Presents Research Highlighting Burden of Idiopathic Pulmonary Fibrosis (IPF) and Use of a Bayesian Statistical Analysis for LYT-100 (Deupirfenidone) at CHEST 2024 Annual Meeting

Business Wire October 9, 2024

PureTech to Present at CHEST 2024 Annual Meeting

Business Wire October 1, 2024

PureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults

Business Wire September 27, 2024

PureTech Founded Entity Vor Bio Announces New Clinical Data Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies

Business Wire September 6, 2024

PureTech Health plc - Half-Year Report

Business Wire August 28, 2024

PureTech Appoints Michele Holcomb, PhD, to Board of Directors

Business Wire August 22, 2024

PureTech Health: Notice of Half-Yearly Results

Business Wire August 21, 2024

PureTech Founded Entity Seaport Therapeutics Appoints David Wheadon, M.D., to its Board of Directors

Business Wire August 13, 2024

PureTech Founded Entity Vedanta Biosciences Expands Leadership Team and Appoints Head of Commercial

Business Wire July 23, 2024

PureTech Health: Completion of Tender Offer & Total Voting Rights

Business Wire June 24, 2024

PureTech Health: Results of the Tender Offer

Business Wire June 24, 2024

PureTech Announces Change of Board Role

Business Wire June 20, 2024

PureTech Founded Entity Seaport Therapeutics Appoints Seasoned Executives to Management Team

Business Wire June 18, 2024

PureTech Health: Results of Annual General Meeting

Business Wire June 13, 2024

PureTech Health: Result of General Meeting

Business Wire June 6, 2024

PureTech Founded Entity Akili Interactive and Virtual Therapeutics Announce Entering Into Definitive Merger Agreement to Establish Leading Digital Health Company

Business Wire May 29, 2024

PureTech to Present at the Jefferies Global Healthcare Conference

Business Wire May 23, 2024

PureTech Founded Entity Vedanta Biosciences Enrolls First Patient in Pivotal Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile Infection

Business Wire May 21, 2024